Immunoprecise Antibodies Ltd (IPA) Annual Income Statement

Annual · GAAP · USD millions

Access IPA quarterly income statements →
Observing income statement movements over recent quarters helps explain how Immunoprecise Antibodies Ltd adapts pricing, costs, and operating efficiency.

View historic periods: Download as CSV:

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Annual Report, GAAP in USD millions ITEM	(Apr 30 2024) 2024	(Apr 30 2023)